https://www.thebodypro.com/category/hiv-prevention-methods/tag/latinx

The Latest

long road ahead

This Week in HIV Research: Do As We Say, Not As We Do

July 9, 2020: Abysmal HIV testing rates in U.S. ambulatory care settings; STI testing frequency in PrEP users; trends in U.S. PrEP uptake; integrating opioid therapy with HCV care in people who inject drugs.

By Barbara Jungwirth and Myles Helfand
white man black man

This Week in HIV Research: Existing Solutions Won't Close the Race Gap

June 18, 2020: Existing evidence-based interventions aren't enough to close HIV's racial gap; transgender patient outcomes in the HIV care continuum; meeting long-term needs of formerly incarcerated people; acute respiratory illness severity and HIV status.

By Barbara Jungwirth and Myles Helfand
Johanne Morne and Dr. Oni Blackstock

Ending the HIV Epidemic Is a Team Effort. The New York City and State Health Departments Discuss Their Combined Work

Johanne Morne, M.S., and Oni Blackstock, M.D., sat down with TheBody to discuss their successes and their work to close the disparities gap.

By Terri Wilder, M.S.W.
Customer giving medical prescription to pharmacist

What Needs to Happen Before California Pharmacies Can Sell PrEP and PEP Without an Initial Prescription

Pharmacists will increasingly play a role in pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) access in California.

By Larry Buhl
Scientist holding slide with blood sample in lab

This Week in HIV Research: U=U Grows Ever Stronger

Oct. 10, 2019: Long-term viral suppression = zero genital tract shedding among women; HIV treatment initiation and sexual risk among MSM; PrEP interest vs. uptake among trans women of color; polypharmacy among people living with HIV.

By Barbara Jungwirth and Myles Helfand
Young people walking with the Lincoln Memorial in the background

Washington, D.C. Youth Face Barriers to HIV Prevention and Sexual Health

Young people in the nation's capital are living in the middle of some of the worst structural and systemic inequalities in America. We should be helping them out.

By Chase Alston
young woman taking blue pill

Four PrEP Studies Address Challenges and Best Practices for Uptake and Retention

Four recent studies in JAIDS chiefly focused on PrEP provision to cisgender women and gay and bisexual men.

By Barbara Jungwirth
AIDS Activists Hold March And Rally In New York City

Ending the HIV Epidemic Will Take More Than Medicine

Our HIV research agenda has to address the world outside of a clinical trial, vaccine researcher Stephaun E. Wallace, Ph.D., argues.

By Stephaun E. Wallace, Ph.D.
Doctor preparing a vaccine for injection

Despite Uptick, Black and Latinx People Have Relatively Low Participation in HIV Vaccine Trials

HIV vaccine researchers are working to study and solve the problem, with a focus on how researchers themselves can more deeply build and earn trust.

By Stephen Hicks
Promo Image

This Week in HIV Research: The PrEP Sex/Race Gap

PrEP access appears far from equal in the U.S.; HIV treatment and viral suppression disparities in Europe; how today’s hepatitis C treatments affect mortality; sex-based differences in cognitive impairment.

By Barbara Jungwirth and Myles Helfand